Items where Author is "van Leth, F."

2023

Domínguez, J. and Boeree, M. J. and Cambau, E. and Chesov, D. and Conradie, F. and Cox, V. and Dheda, K. and Dudnyk, A. and Farhat, M. R. and Gagneux, S. and Grobusch, M. P. and Gröschel, M. I. and Guglielmetti, L. and Kontsevaya, I. and Lange, B. and van Leth, F. and Lienhardt, C. and Mandalakas, A. M. and Maurer, F. P. and Merker, M. and Miotto, P. and Molina-Moya, B. and Morel, F. and Niemann, S. and Veziris, N. and Whitelaw, A. and Horsburgh, C. R. and Jr., and Lange, C. and TBnet, and Resist-TB networks, . (2023) Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement. The Lancet infectious diseases, 23 (4). e122-e137.

Theilmann, M. and Ginindza, N. and Myeni, J. and Dlamini, S. and Cindzi, B. T. and Dlamini, D. and Dlamini, T. L. and Greve, M. and Harkare, H. V. and Hleta, M. and Khumalo, P. and Kolbe, L. M. and Lewin, S. and Marowa, L. R. and Masuku, S. and Mavuso, D. and Molemans, M. and Ntshalintshali, N. and Nxumalo, N. and Osetinsky, B. and Pell, C. and Reis, R. and Shabalala, F. and Simelane, B. R. and Stehr, L. and Tediosi, F. and van Leth, F. and De Neve, J. W. and Bärnighausen, T. and Geldsetzer, P.. (2023) Strengthening primary care for diabetes and hypertension in Eswatini: study protocol for a nationwide cluster-randomized controlled trial. Trials, 24. p. 210.